Revelation Biosciences's total assets for Q1 2024 were $14.70M, an increase of 3.40% from the previous quarter. REVB total liabilities were $5.23M for the fiscal quarter, a -3.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.